Public Company News

FinVolution's Philippine Subsidiary Cooperates with SeaBank Philippines, Propelling Regional Growth

SHANGHAI, March 28, 2024 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced that itsPhilippines financial application, Juanhand, has entered into a strategic cooperation agreement with SeaBank Philippines Bank ("SeaBank"),...

2024-03-28 17:30 4181

36Kr Holdings Inc. Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

BEIJING, March 28, 2024 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company" or "We") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today announced its unaudited financial results for the fourth quarter and fiscal year en...

2024-03-28 17:00 3810

"Bleach: Brave Souls" Thousand-Year Blood War Zenith Summons: Reinforcements Featuring Meninas, Rangiku, and Yumichika Begins March 31 Alongside a Spring Festival Campaign

TOKYO, March 28, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action gameBleach: Brave Souls will be holding the Thousand-Year Blood War Zenith Summons: Reinforcements fromSunday, March 31. See the original press release (https://www.klab.com/en/press/...

2024-03-28 15:40 2878

BEST Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

HANGZHOU, China, March 27, 2024 /PRNewswire/ -- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"), a leading integrated smart supply chain solutions and logistics services provider inChina and Southeast Asia ("SEA"), today announced its unaudited financial results for the fourth quarter and fiscal...

2024-03-28 06:00 4155

IT Tech Packaging, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

BAODING, China, March 27, 2024 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced its unaudited financial results for the fourth quarter and audit...

2024-03-28 04:30 4058

Ascentage Pharma Announces 2023 Annual Results

SUZHOU, China and ROCKVILLE, Md., March 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its annual results for the full year 2023. During...

2024-03-27 22:30 3469

Jereh Ships 7000 HP Electric Fracturing Fleet to Renowned US Oilfield Service Company

HOUSTON, March 27, 2024 /PRNewswire/ -- In Q4 2023, Jereh announced a successful order to provide a complete electric fracturing fleet to a renowned oilfield service company inthe United States. The order includes Jereh 7000 HP electric hydraulic fracturing fleet, as well as auxiliary equipment. ...

2024-03-27 21:00 3430

Cheche CEO Lei Zhang Highlights the Strategic High Ground of Car Insurance for Auto Makers at China EV100

BEIJING, March 27, 2024 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that Lei Zhang, Founder and co-CEO of Cheche Group, delivered a speech at the recent China EV...

2024-03-27 21:00 3358

CARsgen Announced 2023 Annual Results

SHANGHAI, March 27, 2024 /PRNewswire/ -- March 27, 2024, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2023 Annual Results. Business Highlights * Z...

2024-03-27 20:50 3437

Ping An of China CSI HK Dividend ETF(3070.HK)Named Best Performer at Bloomberg Businessweek Top Fund Awards 2023

HONG KONG, March 27, 2024 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) Company Limited ("PAAMC HK"), the offshore asset management arm of the Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An"), announces that its flagship ETF,Ping An of China CSI HK Dividend ETF(3070.HK)...

2024-03-27 18:21 2702

Autohome Inc. Issues 2023 ESG Report

BEIJING, March 27, 2024 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers inChina, today issued its 2023 Environmental, Social and Governance ("ESG") report. The report outlines Autohome's comprehensive l...

2024-03-27 17:30 2928

Viomi Announces Receipt of Minimum Bid Price Notice from Nasdaq

GUANGZHOU, China, March 27, 2024 /PRNewswire/ -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ: VIOT), a leading IoT @ Home technology company inChina, today announced that it has received a written notification from the staff of the Listing Qualifications Department of the Nasdaq ...

2024-03-27 16:00 3084

Waterdrop declared a special cash dividend, the aggregate payment of which amounted to approximately US$15 million

BEIJING, March 27, 2024 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the three months and full year endedDecember 31, 2023 and a special ca...

2024-03-27 14:35 2921

Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology

SEONGNAM, South Korea and AURORA, Colo., March 26, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Raul...

2024-03-27 06:00 1770

X Financial Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

SHENZHEN, China, March 26, 2024 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company" or "we"), a leading online personal finance company inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2023. Fourth Quarter and Fiscal Year 2023 O...

2024-03-27 04:50 2185

Keymed Biosciences Announces 2023 Annual Results and Business Updates

* Submitted a New Drug Application (NDA) of Stapokibart (CM310) for the treatment of moderate-to-severe AD in adults. The NDA was accepted by theChina's NMPA and granted priority review. * Advanced a Phase III clinical study of Stapokibart for the treatment of CRSwNP in 2023. The results of t...

2024-03-27 01:16 2291

Datasea Enters into 5G AI Multimodal Communication Cooperation Agreement Expected to Expand its China 5G Services Revenue

The Agreement with an Estimated Value of $30 Million Supports its Revenue Guidance of$86 Million, a 1,128% Year-Over-Year Increase for its Full Fiscal Year BEIJING, March 26, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada corporation engaged in innovative ...

2024-03-26 22:00 2484

WuXi Biologics Reports Solid 2023 Annual Results

Revenue Increased by 11.6% Y-o-Y to RMB17,034.3 Million Gross Profit Rose by 1.5% to RMB6,827.9 Million Non-COVID Revenue Achieved 37.7% Y-o-Y Growth, Strong Momentum Sustained Non-COVID Late-Phase and Commercial Manufacturing Revenue Grew by 101.7% Y-o-Y "R" in CRDMO Thrived with Extended Part...

2024-03-26 21:53 3931

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

- New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO's analysis of tumor microenvironment SEOUL, South Korea, March 26, 2024 /PRNewswire/ -- Lunit (K...

2024-03-26 21:00 2328

TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients

* TU7710 has the potential to be a highly effective and long-acting treatment for bleeding episodes as well as for preventing bleeding during surgery or invasive procedures in hemophilia patients with inhibitors * Interim results from an ongoing Phase 1a study in healthy male volunteers will ...

2024-03-26 20:00 1822
1 ... 322323324325326327328 ... 765

Week's Top Stories